INTRODUCTION
The importance of suicide needs no emphasis; it is by far the most frequent cause of death from mental disorders, and is among the ten leading causes of death the world over. Earlier research focused mainly on psychological factors in the etiology of suicidal behaviour; biological factors were thought to be non-existent, or at least unimportant. The search for biological markers or etiology of suicidal behaviour was spurred partly by the inability of psychologically oriented studies to adequately explain and predict suicidal behaviour.
OVERVIEW OF BIOLOGICAL MARKERS OF SUICIDAL BE-HAVIOUR
The search for a biological marker for suicide was initiated by the reports of Bunney et al. (1965 Bunney et al. ( ,1969 who found high levels of urinary 17-hydroxycorticosteroids in suicidal depressives though Levy & Hansen (1969) failed to replicate this. As shown in Figure 1 , the important biological markers elucidated so far pertain to Neuroendocrine function and to Monoaminergic neurotransmission.
Thoughactivation of the HypotbalmicPituitary-Adrenal axis (increasedcortisol levels.abnormal Dexamethasone Supression test) has been found to be more common in suicidal than in non-suicidal depressed patients (Traskman et al., 1980; Caroll et al., 1981; Banki et al., 1981 Banki et al., , 1984 Coryell and Schlesser, 1981; Reus, 1982; Targum et al., 1983; Lopez-Ibor et al., 1985) results in nondepressed suicide attempters have been conflicting. An abnormality of the Hypothalmic-Pituitary-Thyroid axis in the form of a blunted Thyroid Stimulating Hormone response to Thyrotropin Releasing Hormone has been related to an increased incidence of completed suicide (Linkowoski et al., 1984) .
Studies of monoamines and monoamine metabolites in the brains of patients who commited suicide were first published in the 1960's aiming to elucidate biological factors in depression which was believed to be the cause of suicide (this is partly true -it is the commonest disorder underlying suicide). In relation to the Dopaminergic system. Traskman et al. (1981) , Montgomery and Montgomery (1982) , and Agren (1983) showed that suicidal depressives had lower CSF homovanillic acid (HVA) the major dopamine metabolite, than nonsuicidal ones. There is reason to believe, however, that low CSF HVA as a predictor of suicide may be limited to depression Ninan et al., 1985) and, therefore, perhaps related to it rather than to suicidal behaviour as such. Further, it may be limited among depressives prone to violent attempts (vide infra) only (Banki et al, 1984) . Van Pragg et al. (1990) , in their stimulating presentation of a hypothesis of the relation between monoamines and abnormal behaviour, have offered evidence to support their view that low dopaminergic activity is related to motor retardation and inertia irrespective of the diagnosis. Whether low CSF HVA is a better predictor of suicide than low CSF 5-hydroxyindoleacetic acid (5-HIAA) or vice-versa is not clear (Banki et al., 1984; Roy et flZ.,1986) .
As regards the Noradrenergic system, only a few studies have investigated CSF levels of 3-methoxy-4-hydroxy phenylglycol (MHPG), the major noradrenaline metabolite, in relation to suicidal behaviour, and the findings have been conflicting.
Initially, Serotonergic system markers were studied in relation to depressive behaviour, but later research also focused on suicidal behaviour as such and considerable, cosistcnt evidence has accumulated relating them to it, as discussed in this paper.
WHY CSF 5-HIAA?
Although various markers of serotonergic activity in the brain are known and have been studied in relation to suicidal behaviour as well, the most commonly studied marker is CSF 5-HIAA (it was the focus of our work, too) because for prediction of suicide, studies have to be antemortem and here the brain is not usually accessible directly; CSF is not very difficult to obtain for study and is a far better representative of brain function than blood or urine. The extent to which marker in the latter two reflect serotonergic neurotransmission in the brain is not clear. 5-HIAA is by far the major metabolite of serotonin, and its levels in the CSF have been shown to correlate with sertonergic function in the brain.
However, CSF 5-HIAA as a marker or predictor of suicide has certain disadvantages viz. hospitalization is required for lumber puncture; a highly standard procedure has to be adopted as nuemerous factors affect its levels (vide infra); a drug-free period is required prior to drawing the sample and lumber punctures do not consent to it.
The present paper, being concerned with the prediction of suicide, will emphasize on CSF 5-HIAA related finding, though briefly reviewing other markers and post-mortem studies.
FACTORS TO BE CONSIDERED IN INTERPRETING THE STUDIES

DIAGNOSIS
A) The diagnostic category of suicidal subjects is important because abnormalities in relation to monoamine activity have been found in nonsuicidal psychiatrically disordered patients, especially depressives, as well. Low CSF 5-HIAA in depression has been reported by numerous studies (Post et al., 1980-review of 15 studies; Gibbon and Davis, 1985) . A greater incidence of low CSF 5-HIAA is found in major depression than in other types (van Pragg and Plutchik, 1984) ; melancholic than in nonmelancholic depression; delusional than in nondelusional depression and more severe melancholic depression (van Pragg et al., 1986) Thus, it is also important to know the subtype and severity of the depression. B) van Pragg et al. (1986) argued that the retrospective diagnosis of Nondepressed suicide attempter was unreliable because a depressive syndrome prior to the attempt is very common (Beskow, 1979; van Pragg, 1982a,b) , and the rated severity of depression decreases substantially after the suicide attempt ( van Pragg and Plutchik, 1985) the hypothetical cathartic effect of attempted suicide.
REPRESENTATIVENESS OF THE SAMPLE
Most research in biological psychiatry is conducted at tertiary referral centres and it is usually not known how far the sample represents the usual patients. Treatment resistant patients and otherwise complicated cases who may be biologically deviant are probably overrepresented in such samples (Asberg et al., 1986 a) .
CRITERION FOR SUICIDAL BE-HAVIOUR
Three indicators of suicidal behaviour have been used: 1) suicidal attempt 2) completed suicide Which of these is used makes all the differences. Most studies (including my own work) focused on suicidal attempters. However, there is an important difference between suicide attempters and completers. Only about 2% of suicide attempters actually commit suicide in the first year after the attempt (Ettlinger, 1975) . In most cases it can be determined that the subject did not definitely intend to die.
Most rating scales view suicidal ideation and attempts as a continuum of increasing severity of suicidal tendency. Though this may be justified in the assessment of suicidal risk, biological markers of suicidal thoughts may be very different from those of actual attempts (Asberg et al., 1986 a) . Notably, Asberg et al. (1976) found that CSF 5-HIAA was correlated with suidides attempts but not to suicidal ideation or rated suicide risk and this has been found in my studies of depressed and schizophrenic suicide attempters as well, though others found correlation with both, as discussed below.
RECENT OR LIFETIME SUICIDE ATTEMPTS
It is important to distinguish a correlation with recent suicidal attempts which may reveal a state marker, from correlation with lifetime suicidal attempts which may yield a trait marker.
SERIOUSNESS OF THE SUICIDAL ACT
Suicidal acts have frequently been divided into violent and nonviolent depending on the method used (Paykel and Rassaby, 1978) . Drug overdose and superficial wrist cutting are nonviolent suicide, while all other methods are trait violent.
3) rating scale of suicidal tendency The studies of CSF 5-HIAA in relation to suicidal behaviour in depression and other psychiatric disorders are summarized in table 1. All the studies which considered a recent suicidal attempt found a low CSF 5-HIAA. Of studies which used lifetime history of suicide attempts as a variable all but two found low CSF 5-HIAA correlated with it. Even the negative study of Roy-Byrnes al. (1983) found low CSF 5-HIAA in suicide attempters when unipolar cases were considered separately. The higher proportion of bipolar patients in their sample then explains the negative overall result. Roy et al. (1985) , the same group which had reported a negative correlation in schizophrenia between CSF 5-HIAA and lifetime suicidal ideas or attempts (Ninan et al., 1984) failed to reproduce their findings. Roy et al. (1990) failed to find lower CSF 5-HIAA in patients of DSM-IIl alcohol dependence with history of lifetime suicide attempts. Possible reasons for the negative findings include remoteness of the attempts (the correlation with low CSF 5-HIAA is strongest for recent attempts; van Pragg, 1991), small proportion of violent attempts, failure to exclude depression not amounting to DSM-III diagnosis in the non-attempters, and the known relationship between alcohol dependence and depressive disorders. Low CSF 5-HIAA has been found in abstinent alcoholics without suicide attempts (Ballenger et al., 1979; Banki, 1981) .
The postmortem CSF study in completed suicides of Kauert et al. (1981) found increased serotonergic activity. However, the time of death of suicides and controls was not similar or compensated for, which may explain this anomalous finding. Studies using rating scales for suicidality also found a negative correlation with CSF 5-HIAA.
The studies do not agree on: 1) Whether CSF 5-HIAA is negatively correlated with ratings of suicidality; 2) Whether CSF 5-HIAA is negatively correlated with suicidal ideation with suicidal acts and 3) Whether CSF 5-HIAA is lower in violent than in nonviolent suicides.
The relationship with CSF 5-HIAA to suicidality has been demonstrated in depression, schizophrenia, personality disorders, alcoholism, adjustment disorders, etc. and in relation to current ratings of suicidality, recent suicide attempts, and lifetime suicide attempts. Thus, the evidence for this correlation is quite robust.
I would now like to briefly present my three studies on serotonergic markers in relation to suicidal behaviour. In all three CSF 5-HIAA and platelet/plasma/serum serotonin were chosen as markers of serotonergic neurotransmission but results with the latter being inconsistent are not being discussed here.
The factors affecting CSF5-HLAA leve^' were controlled: age, sex and body height >J?y matching the study groups and the control group; physical diseases which may affect CSF 5-HIAA were an exclusion criterion; effect of medication by a drug-free period of one week in the first two studies and of two weeks in the third, and in the study on schizophrenics, by excluding those on depot antipsychotics; dietary factors by prohibiting certain foodstuffs and by overnight testing before lumber puncture; effect of physical activity by bed rest and ensured sleep prior to the lumber puncture; time of the day, position of the patient for lumber puncture, intervertebral space used, amount of CSF drawn, handling and storage of CSF, and analytical method used were the same in all subjects.
In all the three studies, psychiatrically normal controls were drawn from patients undergoing spinal anesthesia for surgery who had no past, present, or family history of mental disorder.
The first study, on schizophrenics, used the sulfinpyrazone technique of accumulation of 5-HIAA in the CSF while the other two measured basal CSF 5-HIAA.
The first two studies, on RDC schizophrenics in 1986 and on RDC primary depressives in 1987, were similar, and I will discuss them together. The schizophrenics were evaluated on the Modified Brief Psychiatric Rating Scale (MBPRS; Overall and Gorham, 1962) and the depressives on the Hamilton Rating Scale for Depression (Hamilton, 1960) . In addition, the Suicidal Intent Qustionnaire (SIQ) developed and evaluated at our department by Gupta et al. (1983) , of which team I was also a part, was used in both studies. The questionnaire divides patients into definite communicators (score < =5), partial communicators (score 2-4), and noncommunicators (score < =1). Partial communicators were excluded from the study.
In the study of schizophrenics, 20 definite communicators, 20 noncommunicators, and 10 normal controls were studied. The study on depressives including 15 subjects of each category. Six of the 20 definite communicator schizophrenics had attempted suicide in the index episode (5 violently and 1 nonviolently) while 3 of the 15 definite communicator depressives had done so (2 violently and 1 nonviolently).
The findings supported the following main conclusions: * The severity of the disorder did not correlate with CSF 5-HIAA levels as shown by absence of a significant correlation with MBPRS or HRSD scores. * However, CSF 5-HIAA did show a correlation with components of these scales. In definite schizophrenics it was significantly (p<0.05) negatively correlated with the Anxiety-Depression derived variable of the MBPRS, i.e. those with lower CSF 5-HIAA had higher score on the Anxiety-Depression variable. CSF 5-HIAA was significantly negatively (p < 0.01) correlated wirh the suicide item of the HRSD in the depressives. * We concluded indirectly that low CSF 5-HIAA was significantly correlated only with suicide attempts and not with suicidal ideation alone because : in both schizophrenics and depressives, CSF 5-HIAA of suicide attemptors among the definite communicators was significantly less than that of normal controls (p<0.05 for schizophrenics arid p<0.01 for depressives; Figure 2 and 3); in both studies, both communicators and noncommunicators and nonattempters among the definite communicators did not have significantly different CSF 5-HIAA than normal controls ( Figure 2  and 3) ; CSF 5-HIAA was not significaantly correlated to SIQ scores in either diagnostic cateegory, when CSF 5-HIAA of definite communicators (with or without a suicidal attempt) was compared with that of non-communicators and normal controls.
In the schizophrenics, there was a maximum trend for CSF 5-HIAA to be lower in definite communicators than in normal controls, though it did not reach statistical significance (Figure 4 ). In the depressives, CSF 5-HIAA of definite communicators was less than that of non-communicators (p<0.01) and normal controls (P< 0.001), while that of noncommunicators was not significantly different from that of normal controls ( Figure 5 ).
In our third study, done in 1988, we moved from questionnaire rating of suicidality that covered both suicidal ideation and attempts with only a few patients having history of a suicide attempt, to a direct study of suicide attemptors. Three groups were evaluated: 1) 23 nonpsychotic nondepressed subjects with a history of recent nonviolent suicide at-tempt. One patient had also made an attempt in the past.
2) 14 RDC primary depressives (two-third bipolar and one-third unipolar). Eight had recent attempts (two had past attempts as well ) while six had only past attempts (defined as more than 6 months prior to evaluation). Of the total of 18 suicide attempts in this group, 10 were violent and 8 were nonviolent.
3) 10 normal controls
As in the previous studies, severity of the disorder (HRSD scores) did not correlate significantlywith the CSF 5-HIAA. CSF 5-HIAA in the different groups is shown in Figure 6 , 7 and 8. These finding suggest that low CSF 5-HIAA is correlated : 1) To suicide attempts irrespective of the presence or absence of depression. 2) More strongly to violent attempts to CSF 5-HIAA than to nonviolent attempts, though significantly to both.
The correlation of suicide attempts to CSF 5-HIAA may apply more so to unipolar depressives as they had significantly (p < 0.001) lower CSF 5-HIAA than bipolar depressives (Figure 9 ) which was also found by Roy-Byrne et al. (1983) who analysed unipolar and bipolar patients separately. CSF 5-HIAA, though reported to be low even in those with only past suicide attempts, may be lower in those with recent attempts as among the depressives we found it to be lower in those with recent attempts than in those with past attempts only, though this difference did not reach statistical significance (Figure 10 ). 
PERSISTENCE OF A LOW CSF 5-HIAA
The assessment is difficult and rarely done because: 1) There is a variation in CSF 5-HIAA concentrations with the time of the year (vide supra). 2) Only few patients are available as most are on drugs and/or do not give their concent for a repeat lumber puncture (once recovered).
3) The few patients available may be nonrepresentative. etal. (1972) found CSF 5-HIAA levels to be stable in 8 subjects followed for 3-59 weeks, van Pragg (1977) reported that in 50 subjects followed for more than six months, CSF 5-HIAA levels were stable in those with normal levels and in more than 50% off those with low levels, the rest having normalized. TraskmanBendz et al. (1984) who studied 11 subject over 2-7 years found the levels stable in those with normal levels while they rose in those with low levels, though not to normal.
Coopen
Thus, at present low CSF 5-HIAA appears to be stable over liited periods at least in most patients and if it does increase, it does not return to normal in those periods. It also tends to be similar in each episode of depression.
LOW CSF 5-HIAA AND SUB-SEQUENT COMPLETED SUICIDE
Asbergef a/. (1986b) followed 76 suicide attemptors for one year and reported that 21% of low CSF 5-HIAA patients committed suicide while 2% of those with normal or high CSF 5-HIAA did so. As mentioned already, CSF 5-HIAA level tends to be similar in subsequent episodes in many patients. Asberg et al. (1986b) made repeated estimations in two patients who subsequently committed suicide and in both the CSF 5-HIAA was substantially reduced in the second estimation compared to the first. They suggested that some patients of depression may have low as well as stable CSF 5-HIAA. Perhaps a low and decreasing CSF 5-HIAA may be the most ominous sign of all. Roy et al. (1986 b) also found an increased incidence of completed suicide in suicide attempters with low CSF 5-HI AA. They studied 27 cases of major depression (22 unipolar and 5 bipolar) of which 19 had attempted suicide, 3 by violent and 16 by nonviolent methods of which 4 had recently attempted. The difference between attempters and nonattempters was maximum for 5-HIAA. In one year follow up 4 completed suicide which included 3 of the 7 with low CSF H VA and 2 of the 8 with low CSF 5-HIAA. Lopez-Ibor et al. (1985) reported that the two patients with the lowest CSF 5-HIAA levels in their sample had to be later withdrawn from the study due to risk of suicide; both committed suicide within one year of termination of the study of a subsequent relapse. Traskman et al. (1981) who followed up 119 patients for about a decade reported that all the 7 who had committed suicide had CSF 5-HIAA below than median. As Table 2 shows, there are several markers of serotonergic activity -its precursor, the parent compound, its binding sites, the enzyme degrading it, and its metabolite, which are related to the brain itself or to the platelet as a model for brain serotonergic activity. As they have little value in themselves as predictors of suicidal behaviour, only some of them will be discussed very briefly.
SUICIDAL BEHAVIOUR AND OTHER MARKERS OF SEROTON-ERGIC NEUROTRANSMISSION
BRAIN (Postmortem studies)
The findings are generally consistent with reduced serotonergic activity in the brain of suicide victims.
1. Serotonin 2.5-HIAA Some but not all studies have found lower concentrations of serotonin or 5-HIAA in brains of completed suicides, either in the hind brain or in the hypothalamus ( Asbcrg et al., 1986b-review of 7 studies). Mann et al. (1989) who reviewed 12 studies of serotonin and 5 studies of 5-HIAA levcss in the brains of suicide victims observed that some, but not all, studies reported modestly lower levels of 5-HIAA and/or 5-HT in the brain-stem but not the cortex. Lloyd et al. (1974) estimated serotonin and 5-HIAA in neurons are placed rather than larger segments of brain matter and found lower serotonin concentrations in two of the nuclei. The disparate results of other studies may be due to a failure to study discrete enough segments.
[3H]
Imipramine binding -It is probably related to and the best marker for the presynaptic serotonin uptake site. Contradictory results (higher, normal or lower binding) have been reported in suicide victims since the initial report of fewer binding sites by Stanley et al. (1982) (Mann et al., 1989 -review of 8 studies). Possible methodological reasons for the contradictory findings have been discussed by Mann et al. (1989) . Whether or not 5-HTi receptors or their subpopulations are increased in the brains of suicide victims is not clear though Meltzer (1988) has reported an increase in 5-HTIA receptors.
Spiroperidol binding -It is a marker of post synaptic serotonin-2 binding sites. Owen et al. (1983) and Staley and Mann (1983) reported increased binding, consistent with decreased serotonergic neurotransmission suggested by the CSF studies. The majority, Though not all, studies have found an increased number of 5-HT2 receptors in the pre-frontal cortex of suicde victims which is consistent with decreased serotonergic activity (Mann et al., 1989) . et al. (1975) found lower MAO activity in alcoholic suicide victims than in controls, Grote et al. (1974) and Mann and Stanley (1984) found it to be similar to controls.
MAO activity -While Gottfries
BLOOD
1. Platelet activity - Buchsbaum et al. (1976) reported increased incidence of suicide attempts in subjects with very low platelet MAO These findings seem to suggest that low CSF 5-HIAA may be a trait marker. On the other hand, the possibility that a decreasing CSF 5-HIAA may represent the highest risk for suicide, the stronger correlation with recent suicide attempts than lifetime attempts, and the change in CSF 5-HIAA levels with time (though perhaps not to normal) indicate a" state character of the marker.
In my opinion it is not essential to view low CSF 5-HIAA as either a state marker or a trait marker -it may be both. Like van Pragg et al. (1990) , I view CSF 5-HIAA as representing not any specific diagnostic categories or even a personality variable, but as a functional psychobiological defect. The biological correlate of this defect (CSF 5-HIAA) could be found both as a trait and a state marker.
4. What is the functional defect of which low CSF 5-HIAA is a correlate?
Psychoanalytic authors have stressed that both depression and suicide are related to aggression directed towards the self (Freud, 1953) . Menninger (1933) conceptualized the "wish to kill" as an element of the suicidal act. There is also considerable evidence (Brown et al., 1979 (Brown et al., , 1982 Valzeli, 1981; Linnoila et al., 1983; Lidberg et al., 1984 Lidberg et al., , 1985 Brown and Goodwin, 1986 ) linking low CSF 5-HIAA to outwardly directed aggression, especially, like suicide attempts, of an impulsive and more violent type.
Thus, low CSF 5-HIAA may represent the functional defect of a disordered (especially impulsive and violent) aggression and autoaggression, both as a personality trait and as a state, and thus link depression, suicide, and externally directed aggression where it is found. Asberg et al. (1986a) noted that the impulsive nature of suicidal or aggressive acts which have been correlated with low CSF 5-HIAA may explain why it appears to be related to suicidal acts but not to suicidal ideation (though this latter is controversial). It is interesting to note that it is suspected that correlation of low CSF 5HIAA and suicide is limited to unipolar depression, where the autoaggression hypothesis of depression is more likely to be valid than in bipolar disorder. However, Mann et al. (1989) have offered an alternative hypothesis that a decreased CSF 5-HIAA level is already associated with bipolar disorder, and any further decrease which may be associated with suicidal behaviour is less easily demonstrated.
5. Is low CSF 5-HIAA genetic Or environmental in origin?
While the familial nature of the marker and data from twins (Sedvall et al. 1980 (Sedvall et al. a,b, 1984 higher concordance for CSF 5-HIAA in monozygotic than dizygotic twins) may support a genetic basis, findings in animals suggest that it may resuit from learned helplessness situations (Anisman et al., 1980) or prolonged social isolation (Valzelli, 1981) . Psychological processes do not occur in a biological vacuum and the marker may well be acquired.
6. How does low serotonin turnover interact with other factors in depression and suicide? Asberg et al. (1986b) hypothesized that the marker may represent a vulnerability to depression, suicide, and external aggression. It may manifest in a suicide attempt only when significant adverse events occur or when perception of the situation is distorted by depression ( Figure 11 ). Previous adverse events (e.g., early parental loss) may facilitate a more negative interpretation of the adverse events while factors like social support may contribute to ameliorating the effects of adverse events and depression. Thus, the authors note, we may be moving towards a psychobiology of suicide. Mann et al. (1989) have hypothesized that neurotransmitter systems other than serotonergic probably determine whether the aggression is directed inwards (suicide) or outwards. Carrot et al. (1981) opined that the Dexamethasone Suppression Test identifies a group of suicidal subjects different from that identified by low CSF 5-HIAA. This needs further study as Traskamn et al. (1980) found high levels of Cortisol in the same depressed patients in whom low 5-HIAA was found.
TREATMENT IMPLICATIONS
The correlation between low CSF 5-HIAA and suicidal behaviour leads logically to the implication that drugs that enhance serotonergic activity should be evaluated as a specific treatment for it. Montgomery and Montgomery (1982) found that zimelidine , a selective serotonin reuptake inhibitor decreases suicidal ideas at the beginning of treatment. However, recent case reports associated treatment with fluoxetine with increase in suicidal ideation. Lopez-Ibof et al. (1989) found (nonsignificant) trends for patients with suicide attempts, greater self-aggressivity, and lower CSF 5-HIAA levels to improve with treatment with 5-hydroxytrytophan (a serotonin precursor). Morand et al. (1983) and Volavka et al. (1990) found trytophan to diminish aggressive behaviours in chronic schizophrenics. It has been suggested that drugs like carbamazepine, lithium and propranolol, which are effective in some cases of aggression, have important interactions with serotonergic systems and should be evaluated in impulsive suicidal behaviour (Editorial, Lancet, 1987) . Mann et al. (1989) have suggested that antidepressants may be effective in non-depressive suicidal behaviours as well due to effects on the 5-HT2 and B receptors opposite to those found in the brains of suicide victims.
CONCLUSIONS
Markers of central serotonergic activity, especially CSF 5-HIAA, may be one of the strongest predictors of suicidal behaviour. Sidney- Jones et al. (1990) found that while elderly suicide attempters had significantly lower CSF 5-HIAA levels than non-attempters, the Buss-Durkee Hostility Inventory (measure of aggression and impulsivity), the Brief Psychiatric Rating Scale, the Hamilton Depressive Rating Scale and the Recent Life Changes Questionnaire failed to distinguish the two groups. However, the predictive ability of these markers needs to be evaluated by prospective studies. The author is at pains to emphasize that this review focussing on one important biological variable should not be viewed as an oversimplified , reductionist etiology of suicide. Psychological processes not only interact with biological factors but have biological correlates and results as well: the brain is the seat of the mind. It cannot be assumed (as in much of biological psychiatry) that these markers are the biological cause rather than the biological substrate of the psychological processes underlying suicidal behaviour: psychological processes do not occur in a biological vacuum. For a unified psychobiological theory of suicide it is suggested that relevant psychological and biological variables be studied in the same group of patients to determine their interrelationships, eventually in prospective studies which would also evaluate their relative predictive ability. Some of the various drugs which interact with serotonergic systems may emerge as a treatment for suicidal behaviour as such in a defined subgroup of patients.
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